Laserfiche WebLink
• Leading molecular point -of -care (POC) platform in <br />the United States, trusted by hospitals, physician <br />offices and urgent care facilities nationwide <br />• High-quality molecular technology targeting <br />COVI D-19 Rd Rp gene <br />• Emergency Use Authorization <br />(EUA) supports flexible near -patient <br />testing environments <br />• Sample types tested direct or in viral <br />transport media (VTM) include: <br />- Throat swab <br />- Nasal swab <br />- Nasopharyngeal swab <br />• ID NOW platform designed with POC in mind <br />____ _............ ._ ___. <br />